USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

v2.5.0

Opposition

Defendant
Name:	Oncogen Pharma (Malaysia) Sdn. Bhd.
Correspondence:	CATHERINE F. HOFFMAN DICKINSON WRIGHT PLLC 350 EAST LAS OLAS BLVD, SUITE 1750 FT. LAUDERDALE, FL 33301 UNITED STATES mhtrademarks@dickinsonwright.com, jdahlgard@dickinsonwright.com, dwtrademarks@dickinsonwright.com, choffman@dickinsonwright.com Phone: 954-991-5420

Serial #:	88810420	Application File	Assignment
Application Status:	ABANDONED - NO STATEMENT OF USE FILED
Mark:	ONCOGEN

Plaintiff
Name:	Astex Pharmaceuticals, Inc.
Correspondence:	STEVEN P. HOLLMAN SHEPPARD, MULLIN, RICHTER & HAMPTON, LLP 2099 PENNSYLVANIA AVENUE, N.W., SUITE 100 WASHINGTON, DC 20006-6801 UNITED STATES shollman@sheppardmullin.com, cbush@sheppardmullin.com, hmilstein@sheppardmullin.com Phone: 202-747-1941

Serial #:	78216191	Application File	Assignment	Registration #:	3197209
Application Status:	REGISTERED AND RENEWED
Mark:	DACOGEN

Prosecution History
#	Date	History Text	Due Date
22	06/01/2022	TERMINATED
21	06/01/2022	BD DECISION: OPP DISMISSED W/ PREJ
20	05/27/2022	W/DRAW OF OPPOSITION
19	04/29/2022	SUSPENDED
18	04/29/2022	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
17	03/18/2022	SUSPENDED
16	03/18/2022	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
15	02/22/2022	SUSPENDED
14	02/22/2022	D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
13	11/22/2021	SUSPENDED
12	11/22/2021	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
11	09/11/2021	EXTENSION OF TIME GRANTED
10	09/11/2021	P MOT FOR EXT W/ CONSENT
9	04/30/2021	EXTENSION OF TIME GRANTED
8	04/30/2021	D MOT FOR EXT W/ CONSENT
7	04/29/2021	P APPEARANCE / POWER OF ATTORNEY
6	03/29/2021	EXTENSION OF TIME GRANTED
5	03/26/2021	P MOT FOR EXT W/ CONSENT
4	01/29/2021	ANSWER
3	12/22/2020	INSTITUTED
2	12/22/2020	NOTICE AND TRIAL DATES SENT; ANSWER DUE:	01/31/2021
1	12/22/2020	FILED AND FEE